HUP0003258A3 - Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands - Google Patents

Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands

Info

Publication number
HUP0003258A3
HUP0003258A3 HU0003258A HUP0003258A HUP0003258A3 HU P0003258 A3 HUP0003258 A3 HU P0003258A3 HU 0003258 A HU0003258 A HU 0003258A HU P0003258 A HUP0003258 A HU P0003258A HU P0003258 A3 HUP0003258 A3 HU P0003258A3
Authority
HU
Hungary
Prior art keywords
napthyridine
carboxamides
oxo
substituted
receptor ligands
Prior art date
Application number
HU0003258A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Neurogen Corp Branford
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp Branford filed Critical Neurogen Corp Branford
Publication of HUP0003258A2 publication Critical patent/HUP0003258A2/hu
Publication of HUP0003258A3 publication Critical patent/HUP0003258A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0003258A 1997-08-25 1998-08-24 Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands HUP0003258A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91818097A 1997-08-25 1997-08-25
PCT/US1998/017513 WO1999010347A1 (en) 1997-08-25 1998-08-24 Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands

Publications (2)

Publication Number Publication Date
HUP0003258A2 HUP0003258A2 (en) 2001-03-28
HUP0003258A3 true HUP0003258A3 (en) 2001-05-28

Family

ID=25439933

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003258A HUP0003258A3 (en) 1997-08-25 1998-08-24 Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands

Country Status (24)

Country Link
EP (1) EP1007526A1 (enExample)
JP (1) JP2001514181A (enExample)
KR (1) KR20010023313A (enExample)
CN (1) CN1268136A (enExample)
AP (1) AP2000001742A0 (enExample)
AU (1) AU753800B2 (enExample)
BG (1) BG104192A (enExample)
BR (1) BR9811362A (enExample)
CA (1) CA2301599C (enExample)
EG (1) EG21717A (enExample)
HU (1) HUP0003258A3 (enExample)
IL (1) IL134291A0 (enExample)
IS (1) IS5382A (enExample)
LV (1) LV12539B (enExample)
NO (1) NO20000822L (enExample)
NZ (1) NZ502548A (enExample)
OA (1) OA11293A (enExample)
PE (1) PE130999A1 (enExample)
PL (1) PL338783A1 (enExample)
SI (1) SI20270A (enExample)
SK (1) SK2162000A3 (enExample)
TW (1) TW574221B (enExample)
WO (1) WO1999010347A1 (enExample)
YU (1) YU10500A (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE289593T1 (de) * 1999-05-06 2005-03-15 Neurogen Corp Substituierte 4-oxo-chinolin-3-carboxamide als gaba gehirnrezeptorliganden
US6448246B1 (en) 1999-05-25 2002-09-10 Neurogen Corporation Substituted 4H-1,4-benzothiazine-2-carboxamide: GABA brain receptor ligands
US6559145B2 (en) 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
US6562822B2 (en) 2000-07-12 2003-05-13 Pharmacia & Upjohn Company Heterocyle carboxamides as antiviral agents
US6730682B2 (en) 2000-07-12 2004-05-04 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
EP1326611B1 (en) 2000-10-12 2007-06-13 Merck & Co., Inc. Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
IL155089A0 (en) 2000-10-12 2003-10-31 Merck & Co Inc Aza and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
CA2425625A1 (en) 2000-10-12 2002-07-18 Merck & Co., Inc. Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
US20020151591A1 (en) * 2000-10-17 2002-10-17 Anabella Villalobos Combination use of acetylcholinesterase inhibitors and GABAa inverse agonists for the treatment of cognitive disorders
JP2004527500A (ja) * 2001-03-01 2004-09-09 ファイザー・プロダクツ・インク 認識障害の治療のためのニコチン受容体部分アゴニスト、エストロゲン、選択的エストロゲン調節剤又はビタミンｅとｇａｂａａ逆アゴニストの併用
AR036256A1 (es) 2001-08-17 2004-08-25 Merck & Co Inc Sal sodica de un inhibidor de integrasa del vih, procesos para su preparacion, composiciones farmaceuticas que lo contienen y su uso para la manufactura de un medicamento
ATE370948T1 (de) 2002-01-17 2007-09-15 Merck & Co Inc Hydroxynaphthyridinoncarbonsäureamide, die sich als inhibitoren der hiv-integrase eignen
WO2003077850A2 (en) 2002-03-15 2003-09-25 Merck & Co., Inc. N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
WO2004106336A1 (en) * 2003-05-27 2004-12-09 Pfizer Products Inc. Process for the preparation and purification of 1,5-naphthyridine-3-carboxyamides
WO2004106334A2 (en) * 2003-05-28 2004-12-09 Pfizer Products Inc. Process for the preparation of 1,5-naphthyridine-3-carboxy amides by direct ester amidation
DK2074123T3 (da) * 2006-10-16 2013-01-14 Bionomics Ltd Nye anxiolytiske forbindelser
DK2083811T3 (en) * 2006-11-22 2017-01-30 Clinical Res Ass Llc PROCEDURES FOR TREATING DOWNS SYNDROME, FRAGILT X SYNDROME AND AUTISM

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204813A1 (es) * 1972-05-08 1976-03-05 Yamanouchi Pharma Co Ltd Proceso para la preparacion de derivados de ampilicina
GB1433774A (en) * 1973-02-26 1976-04-28 Allen & Hanburys Ltd Heterocyclic compounds apparatus for conveying articles
US4374138A (en) * 1981-11-13 1983-02-15 Warner-Lambert Company Antibacterial amide compounds, compositions, and methods of use
DD279887A1 (de) * 1987-07-03 1990-06-20 Inst Pharmakologische Forschun Verfahren zur herstellung von d-alpha-(4(1h)-1,5-naphthyridon-3-carboxamido)-benzylpenicillin und anderen beta-lactamantibiotika
DD295360A5 (de) * 1987-07-03 1991-10-31 Akad Wissenschaften Verfahren zur Herstellung von aktivierten Carbonsäureestern
DD279875A1 (de) * 1987-07-03 1990-06-20 Inst Pharmakologische Forschun Verfahren zur herstellung von aktivierten carbonsaeureestern
JPS6461461A (en) * 1987-09-01 1989-03-08 Otsuka Pharma Co Ltd Benzohetero ring derivative

Also Published As

Publication number Publication date
AU9117398A (en) 1999-03-16
NO20000822L (no) 2000-04-13
WO1999010347A1 (en) 1999-03-04
SI20270A (sl) 2000-12-31
AP2000001742A0 (en) 2000-02-24
PL338783A1 (en) 2000-11-20
BG104192A (en) 2001-05-31
NO20000822D0 (no) 2000-02-18
KR20010023313A (ko) 2001-03-26
CA2301599C (en) 2003-03-25
YU10500A (sh) 2002-10-18
NZ502548A (en) 2002-06-28
OA11293A (en) 2002-11-19
CA2301599A1 (en) 1999-03-04
LV12539B (en) 2001-01-20
HUP0003258A2 (en) 2001-03-28
SK2162000A3 (en) 2001-03-12
TW574221B (en) 2004-02-01
PE130999A1 (es) 1999-12-16
IL134291A0 (en) 2001-04-30
JP2001514181A (ja) 2001-09-11
BR9811362A (pt) 2000-08-22
CN1268136A (zh) 2000-09-27
LV12539A (en) 2000-10-20
IS5382A (is) 2000-02-22
EG21717A (en) 2002-02-27
AU753800B2 (en) 2002-10-31
EP1007526A1 (en) 2000-06-14

Similar Documents

Publication Publication Date Title
AU2218997A (en) Certain fused pyrrolecarboxamides as gaba brain receptor ligands
GB9817407D0 (en) Chiral compounds
AU2217200A (en) 2-amino-9-alkylpurines: gaba brain receptor ligands
HUP0003258A3 (en) Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands
AU2881199A (en) Substituted 1,4-dihydro-4-oxonicotinic carboxamides: gaba brain receptor ligands
IL147971A0 (en) Fused pyrrolecarboxamides: gaba brain receptor ligands
SG70655A1 (en) New spirocyclic compounds
GB9502870D0 (en) Chiral compounds
PL337181A1 (en) Novel salt
IL135729A0 (en) H3 receptor ligands of the phenyl-alkyl-imidazoles type
GB9713732D0 (en) Substituted triazinic compounds
GB2316076B (en) Chiral Compounds
GB9704522D0 (en) Compounds
AU2653499A (en) Oxo-dipyridoimidazole-carboxamides: gaba brain receptor ligands
ZA987957B (en) Substituted 4-oxo-napthyridine-3-carboxamides: gaba brain receptor ligands.
GB9715318D0 (en) Decolourisation process
GB9702978D0 (en) Compounds
CZ2000554A3 (cs) Substituované 4-oxonaftyridin-3-karboxamidy jako ligandy mozkových receptorů GABA
GB9815373D0 (en) Receptor ligands
TW376216U (en) Improved structure for the distributor
GB9711201D0 (en) Chiral phorous-based ligands
ZA9810176B (en) H3 receptor ligands of the phenyl-alkyl-imidazoles type
GB9709580D0 (en) Head mount brain communicator
AU133746S (en) Distributor
GB9707254D0 (en) Improved hurdle